Iovance Biotherapeutics, Inc. (IOVA)
2.87
+0.05
(+1.77%)
USD |
NASDAQ |
Dec 24, 12:59
2.88
+0.01
(+0.35%)
After-Hours: 13:59
Iovance Biotherapeutics SG&A Expense (TTM): 158.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 11.09M |
| Lantheus Holdings, Inc. | 439.11M |
| iRhythm Technologies, Inc. | 470.32M |
| Day One Biopharmaceuticals, Inc. | 116.18M |
| Perspective Therapeutics, Inc. | 31.53M |